Importantly, while our data provide additional insight into the contribution of IRF5 genetic risk to intrinsic T cell abnormalities seen in SLE patients, a primary limitation of this study is that we have yet to examine the functional ability of circulating Tfh and Tfr subsets from risk and non-risk carriers. This evidence concerns the gene TFRC and systemic lupus erythematosus.